Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction

Cardiology

Volumn 120, Issue 4, 2012, Pages 227-234

  De Mulder, Maarten ^a   Van Der Ploeg, Tjeerd ^a   De Waard, Guus A ^a   Boersma, Eric ^b   Umans, Victor A ^a  

^a Location Alkmaar   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndrome; Biomarker; Hyperglycemia; Net reclassification improvement; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; PROTEIN ADMISSION PLASMA GLUCOSE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENT; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; ROC CURVE;

EID: 84856929794     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000335715     Document Type: Article

References (28)

1. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al: Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353. (Pubitemid 37310196)
2. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al: A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-2733. (Pubitemid 38725422)
3. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et al: Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119: 2408-2416.
4. Norhammar AM, Ryden L, Malmberg K: Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-1831. (Pubitemid 29521869)
5. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al: Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164: 982-988. (Pubitemid 38581518)
6. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al: Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619. (Pubitemid 351440650)
7. de Mulder M, Cornel JH, van der Ploeg T, Boersma E, Umans VA: Elevated admission glucose is associated with increased longterm mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J 2010; 160: 412-419.
8. Dandona P, Chaudhuri A, Ghanim H, Mohanty P: Effect of hyperglycemia and insulin in acute coronary syndromes. Am J Cardiol 2007; 99: 12H-8H.
9. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454. (Pubitemid 40396812)
10. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al: Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7. (Pubitemid 36044395)
11. Sinnaeve PR, Steg PG, Fox KA, Van De WF, Montalescot G, Granger CB, et al: Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2009; 169: 402-409.
12. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, WHO Document Production Services, 2006.
13. www.outcomes-umassmed.org/GRACE/ files/GRACE-RiskModel-Coefficients.pdf (accessed 1 June, 2011).
14. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172. (Pubitemid 351193639)
16. www.outcomes-umassmed.org/GRACE/ grace-risk-table.aspx (accessed 1 June, 2011).
17. Ridker PM, Buring JE, Rifai N, Cook NR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 2007; 297: 611-619.
18. Correia LC, Rocha MS, Bittencourt AP, Freitas R, Souza AC, Almeida MC, et al: Does acute hyperglycemia add prognostic value to the GRACE score in individuals with non-ST elevation acute coronary syndromes? Clin Chim Acta 2009; 410: 74-78.
19. Aronson D, Hammerman H, Kapeliovich MR, Suleiman A, Agmon Y, Beyar R, et al: Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function. Diabetes Care 2007; 30: 960-966. (Pubitemid 46556593)
20. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al: Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27: 1289-1297. (Pubitemid 43998101)
21. Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B: Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. Am Heart J 2010; 160: 88-94.
22. Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, et al: Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Am J Cardiol 2010; 106: 650-658.
23. Khan SQ, Narayan H, Ng KH, Dhillon OS, Kelly D, Quinn P, et al: N-terminal pro-Btype natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clin Sci (Lond) 2009; 117: 31-39.
24. Tang EW, Wong CK, Herbison P: Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post-acute coronary syndrome. Am Heart J 2007; 153: 29-35. (Pubitemid 44880880)
25. de Mulder M, Umans VA, Stam F, Cornel JH, Oemrawsingh RM, Boersma E: Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial. Diabet Med 2011; 28: 1168-1175.
26. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890. (Pubitemid 39452604)
27. De Mulder M, Oemrawsingh RM, Stam F, et al: Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycemic myocardial infarction patients. Heart 2012; 98: 37-41.
28. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136. (Pubitemid 46137814)